+20.1%
GSK vs BNS
+49.3%
-29.2%
-19.3%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | BNS | Excess | Alpha |
|---|---|---|---|---|
| 1D | 0.0% | +0.7% | -0.6% | -0.1% |
| 7D | -3.5% | -0.4% | -3.1% | -3.5% |
| 30D | -3.4% | +3.5% | -6.9% | -4.0% |
| 3M | -8.1% | +14.1% | -22.2% | -10.7% |
| 6M | -11.1% | +33.8% | -44.9% | -16.6% |
| YTD | +0.7% | +29.5% | -28.7% | -5.5% |
| 1Y | +20.1% | +48.4% | -28.3% | +14.1% |
| All | +20.1% | +49.3% | -29.2% | +14.1% |
Cumulative growth
Daily Returns
Daily percentage return beside BNS.
Daily Out/Under-Performance
Portfolio return minus BNS return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × BNS return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded BNS wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling